Marshall Wace
RXST icon

Marshall Wace’s RxSight RXST Stock Holding History

Marshall Wace’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.8M Buy
995,916
+983,191
+7,726% +$5.93M ﹤0.01% 1401
2026
Q1 		$78.4K Sell
12,725
-64,607
-84% -$536K ﹤0.01% 2928
2025
Q4 		$806K Buy
+77,332
New +$776K ﹤0.01% 2038
2024
Q3 		– Sell
-324,289
Closed -$19.5M – 2898
2024
Q2 		$19.5M Buy
+324,289
New +$18.5M 0.03% 510
2022
Q1 		– Sell
-6,034
Closed -$68K – 3927
2021
Q4 		$68K Sell
6,034
-11,671
-66% -$140K ﹤0.01% 3484
2021
Q3 		$224K Buy
+17,705
New +$244K ﹤0.01% 2766

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace's RXST Position: Q2 2026 in Review

Marshall Wace increased its RxSight (RXST) stake by 7,726% in Q2 2026, buying an estimated $5.93M and bringing the position to 995,916 shares worth $4.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1401.

Marshall Wace first reported a position in RXST in Q3 2021 and has held it in 6 quarters since. The position peaked at $19.5M in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Marshall Wace held 995,916 shares of RxSight worth $4.8M as of Q2 2026.
  • Marshall Wace bought 983,191 RxSight shares in Q2 2026, an estimated $5.93M.
  • RxSight made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1401 holding.
  • Marshall Wace first reported a position in RxSight in Q3 2021 and has held it in 6 quarters since.
  • Marshall Wace's RxSight position peaked at $19.5M in Q2 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.